Argenx Se (ARGX) EBT Margin (2016 - 2026)

Argenx Se (ARGX) posted EBT Margin of 33.74% for Q1 2026, up 7.58% on a QoQ basis from 31.37% in Q4 2025, and up 813.0% year-over-year from 3.7% in Q1 2025.

Argenx Se (ARGX) EBT Margin (2016 - 2026) Analysis & Trends

Argenx Se's EBT Margin history runs 11 years deep, the most recent figure standing at 33.74% for Q1 2026.

  • Quarterly EBT Margin rose 813.0% year-over-year to 33.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 32.5% (up 1856.0% YoY) and the FY2025 annual result came in at 30.8%, up 2690.0% from the prior year.
  • EBT Margin was 33.74% for Q1 2026 at Argenx Se, up from 31.37% in the prior quarter.
  • Across five years, EBT Margin topped out at 1087.14% in Q1 2022 and bottomed at 904.84% in Q2 2022.
  • A 5-year average of 35.01% and a median of 25.31% in 2023 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2022 — EBT Margin soared 110564 bps — and 2023, when it sank 105220 bps.
  • Argenx Se's EBT Margin stood at 23.78% in 2022, then tumbled by 31 bps to 16.34% in 2023, then plunged by 30 bps to 11.38% in 2024, then jumped by 176 bps to 31.37% in 2025, then climbed by 8 bps to 33.74% in 2026.
  • Business Quant data shows ARGX's EBT Margin at 33.74% in Q1 2026, 31.37% in Q4 2025, and 34.26% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 17.13%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 23.05%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 33.74%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 18.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 33.74%
Dec 31, 2025 31.37%
Sep 30, 2025 34.26%
Jun 30, 2025 30.24%
Mar 31, 2025 25.62%
Dec 31, 2024 11.38%
Sep 30, 2024 15.36%
Jun 30, 2024 -3.14%
Mar 31, 2024 -18.67%
Dec 31, 2023 16.34%
Sep 30, 2023 25.31%
Jun 30, 2023 -31.14%
Mar 31, 2023 34.94%
Dec 31, 2022 23.78%
Sep 30, 2022 183.53%
Jun 30, 2022 -904.84%
Mar 31, 2022 1,087.14%
Dec 31, 2021 -941.05%
Sep 30, 2021 0.03%
Jun 30, 2021 -166.98%